Navigation Links
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Date:1/26/2009

ABBOTT PARK, Ill., Jan. 26 /PRNewswire-FirstCall/ -- Data published online today in Circulation from the SPIRIT III U.S. pivotal trial evaluating the XIENCE V(TM) Everolimus Eluting Coronary Stent System demonstrated that Abbott's market-leading XIENCE V outperforms the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) in reducing major adverse cardiac events (MACE) at two years. In the SPIRIT III trial of 1,002 patients, XIENCE V demonstrated a 45 percent reduction in the risk of MACE, and a 40 percent reduction in the risk of cardiac death or heart attack (myocardial infarction, or MI) at two years in patients treated with XIENCE V compared to those treated with TAXUS. Additionally, at two years the study demonstrated a 32 percent reduction in the risk of target vessel failure (TVF, cardiac events related to the treated vessel) for XIENCE V compared to TAXUS. These published results were first presented in May 2008 at the EuroPCR Congress in Barcelona.

"As published in Circulation, the SPIRIT III study results demonstrate that the clinical benefits of XIENCE V continue to improve between one and two years of follow-up after stent implantation compared to TAXUS," said Gregg W. Stone, M.D., Columbia University Medical Center; chairman, Cardiovascular Research Foundation, New York; and principal investigator of the SPIRIT III trial. "These data reinforce our earlier findings demonstrating the excellent angiographic and clinical results with the XIENCE V stent, resulting in fewer heart attacks and repeat reinterventions."

The SPIRIT III trial demonstrated the following key results for XIENCE V at two years:

-- A 45 percent reduction in the risk of MACE compared to TAXUS (7.3 percent for XIENCE V vs. 12.8 percent for TAXUS, p-value=0.004)*. MACE is an important composite clinical measure of safety and effic
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
2. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
7. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
8. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
9. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
10. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
11. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... SAN ANTONIO , Jan. 15, 2014 Most ... take, according to a recent online survey* sponsored by ... among the National Osteoporosis Foundation online support community, ... to take medication that comes in a form other ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... Fla., April 20, 2011 Legal-Bay LLC, through its ... making a substantial commitment to plaintiffs in need of ... Cases.  Legal-Bay is already an industry leader; however they ... funding areas.  Recently the company announced that they have ...
... 2011 The Society of ... taking a leading role in measuring and assessing radiation ... and reduction of skin dosage; and promoting the safety ... this month in the Journal of Vascular and Interventional ...
Cached Medicine Technology:Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 3Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 4Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 5
(Date:7/11/2014)... adults who screened positive for a history of hazardous ... than 50 percent after receiving mobile phone text messages ... a study published online yesterday in Annals of ... for Young Adult Emergency Department Patients: A Randomized Clinical ... than 50,000 adults ages 18 to 24 visit ERs ...
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer and retailer, has ... To bring more benefits to worldwide clients in this great ... for these brand new items. Clients can enjoy thwe special ... says gladly, “We are happy to announce such a promotion. ... new and old customers and strengthen our relationship with them. ...
(Date:7/11/2014)... Hills, CA (PRWEB) July 11, 2014 Bedros ... marketing expert; a title he’s earned by founding the fast-selling ... professionals on marketing their businesses. He works with successful boot ... blog post on the traits of the most successful ... earners share three important qualities. , “I’ve worked with and ...
(Date:7/11/2014)... H.E.A.R Me Out Listens to Needs of Hearing ... provide comprehensive information and services available to Colorado’s hearing ... with hearing loss, this organization is the first of ... local and state resources that aims to give new ... Me Out and its website was founded by Colorado ...
(Date:7/11/2014)... is history in much of the world, but remains ... vaccinated children an extra dose of inactivated polio vaccine ... infectious disease, a new study suggests. Although the ... as a year after vaccination. Vaccinated children and adults ... of the disease, according to background information in the ...
Breaking Medicine News(10 mins):Health News:Text message medicine: Texts from the ER can reduce binge drinking 2Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Researchers Assess New Way to Boost Polio Immunity 2
... study has found that among women who have never ... increased risk of developing ovarian cancer compared with women ... issue of CANCER , a peer-reviewed journal of ... may contribute to the development of ovarian cancer through ...
... is urging women to continue waging a battle against the Food ... hormones. , ... Potomac, MD (PRWEB) January 2, 2009 ... health practitioner, is urging women to continue waging a battle against ...
... The National Parkinson Foundation (NPF) awarded ... new evidence-based interventions aimed at preventing falls in ... grants to five different research projects at NPF ... and the United States. NPF supports a ...
... asks you to help save lives by donating blood ... being held on Tuesday, January 6th from 2 pm ... Gloucester City, New Jersey. To make an immediate ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) Goldglantz suffered 3rd ...
... while performing winter task , , FRIDAY, Jan. 2 (HealthDay ... can be physically challenging and dangerous work, so you ... the American Academy of Orthopaedic Surgeons (AAOS). , ... U.S. hospital emergency rooms, doctors, offices, clinics and other ...
... key to understanding, and perhaps killing, dormant ovarian cancer ... years later, researchers at The University of Texas M. ... Journal of Clinical Investigation . , The team found ... a switch for autophagy, or self-cannibalization, in ovarian cancer ...
Cached Medicine News:Health News:Study links obesity to elevated risk of ovarian cancer 2Health News:Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones 2Health News:Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones 3Health News:The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative 2Health News:The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative 3Health News:Blood Drive Held in Honor of Gloucester City Resident - Evan Goldglantz 2Health News:Shovel Snow Safely 2Health News:Dormant cancer cells rely on cellular self-cannibalization to survive 2
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Inoculum Broth with Calcium Chloride and Phytone....
...
Medicine Products: